BCS

NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public. So what: If you purchased Barclays securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., August 14, 2026. Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.

Investors need to pay close attention to BCS stock based on the movements in the options market lately.

NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public. So what: If you purchased Barclays securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Barclays PLC Q2 2026 results update disappointed the market, triggering an 8.7% intraday drop from pre-release highs. A strong H1 operating performance along with raised FY26E income targets was not enough to offset concerns on costs and specific segment revenue items. Recent price weakness follows a period of strong performance, suggesting prior market optimism may have been excessive.

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays PLC may have issued materially misleading business information to the investing public.

Barclays (BCS) receives a 'Hold' rating, with a £3.3/share ($17.71 ADR) price target, citing limited risk-adjusted upside. 2Q26 results confirm that headline RoTE above 16% is driven by buybacks and one-offs, not sustainable core improvements. Loan loss rates and cost ratios are rising, while organic net income growth is only mid-range versus European peers.

British lender Barclays logged a 17% increase in profits for the first half of 2026. The profit rise was fueled mainly by strong performance from Barclay's investment banking arm amid an uptick in dealmaking and financial market activity, The Independent reported Tuesday (July 28).

BCS posts higher y/y net income and revenues in Q2 on a stronger balance sheet, but rising operating expenses and credit impairment charges temper the gains.

Barclays PLC (LSE:BARC) delivered a better-than-expected second quarter but investors seemed to focus on weaker net interest income, additional costs and limited scope for forecast upgrades. Shares in the bank fell 5.6% to 500.8p by Tuesday afternoon.